Outsourcing single-use technologies to accelerate speed to market
21 October, 2021To fast-track time to market and gain a competitive edge, pharmaceutical development companies are increasingly implementing single-use technologies.
Empowering researchers to develop genetic medicines
18 October, 2021The Precision Nanosystems NanoAssemblr is a platform of technologies designed to encapsulate a drug or genetic material.
Intestinal drug found to boost memory and cognition
15 October, 2021An existing drug — used to treat constipation — may be able to boost our ability to think more clearly.
Aus buys 300K courses of Merck's oral COVID-19 treatment
06 October, 2021The Australian Government will purchase 300,000 courses of the company's promising oral COVID-19 treatment, should it receive approval from the TGA.
Antidepressants found to inhibit tumour growth in mice
05 October, 2021When combined with immunotherapy the drugs managed to stop the cancer growth long term, and in some cases the tumours disappeared completely.
Monash Uni to launch Victoria's Health Innovation Centre
24 September, 2021The Health Innovation Centre will include a flagship cardiovascular disease-focused research accelerator, HeartLabs, and a new focal point for clinical trials.
ATAGI recommends Moderna for teens, extra doses secured
13 September, 2021 by Lauren DavisThe Australian Government has secured an additional one million doses of Moderna's COVID-19 vaccine, recently approved for adolescents aged 12 to 17 years.
Creating a genetic medicine manufacturing ecosystem: part 2
06 September, 2021 by Peter DavisThe landscape has shifted from a hopeless pipedream to firm steps and to the creation of such an ecosystem, from the unlikeliest places.
Aus teens now eligible for Pfizer, TGA approves antibody treatment
30 August, 2021 by Lauren DavisPfizer's COVID-19 vaccine will soon be available for all Australians 12 years and above, and the TGA grants provisional approval for a novel monoclonal antibody treatment.
Australia's first national biotech incubator established
27 August, 2021Australia's first national biotech incubator is to be established with $40 million funding from the federal government's Medical Research Future Fund.
Inhibitor drug 'primes' the body for anticancer immunotherapy
25 August, 2021Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe and may benefit some patients with advanced cancers.
Smart nanoparticles fight fungal infections
19 August, 2021Newly engineered nanoparticles have demonstrated a remarkable ability to battle one of the most invasive and notoriously resistant fungal infections.
Radio waves improve survival in liver cancer patients
17 August, 2021A targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.
Tiny gel drops culture cells for regenerative medicine
16 August, 2021Micrometre-sized gel drops can provide the extracellular architecture needed for cells to grow and proliferate.
Licence agreement for nasal spray drug delivery platform
13 August, 2021A nasal spray technology that enables the delivery of psychedelic and non-psychedelic drugs to treat mental health disorders will enter development for clinical use.
